ArticleCommunications biology2026

OSBPL3 drives colorectal cancer progression via Hippo-YAP signaling and modulates MEK inhibitor sensitivity.

Yuchen Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.